Sonire Therapeutics Closes $18 Million Series A to Advance HIFU Therapy for Pancreatic Cancer April 15, 2026
STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC-15 April 16, 2026
AIRNA Doses First Patient in Global Phase 1 Study of RNA Editing Candidate AIR-001 for AATD April 17, 2026
NovAccel Secures Financing to Accelerate Medical Radioisotope Production for Next-Generation Cancer Therapy May 12, 2026
Sonire Therapeutics Initiates First U.S. Clinical Trial of Ultrasound-Guided HIFU Therapy in Pancreatic Cancer May 26, 2026
Neusignal Therapeutics Completes Series B Financing to Advance Alzheimer’s Disease Program NTX-083 July 1, 2026
